← Back to Screener
Corvex, Inc. Common Stock (MOVE)
Price$15.89
Favorite Metrics
Price vs S&P 500 (26W)189.34%
Price vs S&P 500 (4W)26.72%
Market Capitalization$28.98M
All Metrics
Book Value / Share (Quarterly)$1.97
P/TBV (Annual)6.61x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-162.51
Price vs S&P 500 (YTD)137.96%
Gross Margin (TTM)-270.20%
Net Profit Margin (TTM)-3409.60%
EPS (TTM)$-59.42
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$-59.42
EPS (Annual)$-39.39
ROI (Annual)-321.07%
Gross Margin (Annual)-196.84%
Cash / Share (Quarterly)$23.95
Revenue Growth QoQ (YoY)60.00%
ROA (Last FY)-209.60%
EBITD / Share (TTM)$-7.38
ROE (5Y Avg)-366.42%
Operating Margin (TTM)-3156.20%
Cash Flow / Share (Annual)$-32.95
P/B Ratio17.71x
P/B Ratio (Quarterly)2.92x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)59.94x
Net Interest Coverage (TTM)-8.38x
ROA (TTM)-225.03%
EPS Incl Extra (Annual)$-39.39
Current Ratio (Annual)3.02x
Quick Ratio (Quarterly)0.31x
3-Month Avg Trading Volume0.98M
52-Week Price Return132.62%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.10
P/S Ratio (Annual)28.61x
Asset Turnover (Annual)0.09x
52-Week High$25.68
EPS Excl Extra (Annual)$-39.39
CapEx CAGR (5Y)-4.36%
26-Week Price Return193.33%
Quick Ratio (Annual)2.32x
13-Week Price Return186.48%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.70x
Enterprise Value$29.97
Asset Turnover (TTM)0.07x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2342.25%
Cash / Share (Annual)$11.55
3-Month Return Std Dev326.62%
Net Income / Employee (TTM)$-1
ROE (Last FY)-322.60%
Net Interest Coverage (Annual)-1.80x
EPS Basic Excl Extra (Annual)$-39.39
Total Debt / Equity (Quarterly)0.02x
EPS Incl Extra (TTM)$-59.42
ROI (TTM)-357.73%
P/S Ratio (TTM)57.97x
Revenue / Share (Annual)$1.68
Tangible BV / Share (Annual)$0.24
Price vs S&P 500 (52W)102.79%
Year-to-Date Return140.60%
5-Day Price Return27.93%
EPS Normalized (Annual)$-39.39
ROA (5Y Avg)-198.71%
Net Profit Margin (Annual)-2342.25%
Month-to-Date Return44.65%
Cash Flow / Share (TTM)$-0.75
EBITD / Share (Annual)$-40.00
Operating Margin (Annual)-2391.12%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-363.73%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-59.42
P/TBV (Quarterly)10.58x
P/B Ratio (Annual)4.87x
Inventory Turnover (TTM)0.82x
Pretax Margin (TTM)-3409.60%
Book Value / Share (Annual)$10.75
Price vs S&P 500 (13W)185.79%
Beta1.02x
Revenue / Share (TTM)$5.87
ROE (TTM)-359.83%
52-Week Low$3.44
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
MOVECorvex, Inc. Common Stock | 57.97x | — | -270.20% | -3156.20% | $15.89 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.65 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.29 |
TMDXTransMedics Group, Inc. Common Stock | 6.58x | 88.21% | 59.92% | 17.93% | $109.12 |
LIVNLivaNova PLC Ordinary Shares | 2.56x | 8.24% | 68.04% | 14.09% | $65.01 |
ITGRInteger Holdings Corporation | 1.63x | 11.55% | 27.39% | 11.90% | $88.37 |
AXGNAxogen, Inc. Common Stock | 7.92x | 14.93% | 74.31% | -3.49% | $37.37 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $37.91 |
BLFSBioLife Solutions Inc. | 10.59x | 14.87% | 64.56% | -17.26% | $20.85 |
INMDInMode Ltd. Ordinary Shares | 2.45x | 12.45% | 78.54% | 23.05% | $14.33 |
CBLLCeriBell, Inc. Common Stock | 8.68x | — | 87.89% | -65.57% | $20.74 |
About
Movano Inc develops medical-grade health wearables designed for women, with the Evie Ring as its flagship product. The device combines advanced sensors to track heart rate variability, blood oxygen saturation, respiratory and skin temperature metrics, menstrual and ovulation cycles, sleep quality, activity levels, and mood. The platform aims to deliver comprehensive, clinical-grade health insights to mainstream consumers through innovative wearable technology.